Literature DB >> 27041097

Aortic Stiffness in Youth with Hypertrophic Cardiomyopathy Genotype.

Justin P Zachariah1, Philip K Johnson2,3, Steven D Colan2,3.   

Abstract

Clinical events in hypertrophic cardiomyopathy (HCM) patients are related to the degree of hypertrophy. Aortic stiffness in adult HCM patients has been reported to be higher than control patients. Increased stiffness may cause more LV hypertrophy and thus lead to more clinical events. We sought to (a) noninvasively compare aortic structure and function between youth with sarcomeric HCM genotype versus control youth and (b) explore the relation between aortic function and degree of left ventricular (LV) hypertrophy. In a prospective study from a single referral center, clinical, anthropometric, and hemodynamic data were acquired on 28 consecutive pathogenic HCM gene mutation carriers and 26 unrelated controls (mean age 16.3, 50 % girls). Hemodynamic data included applanation tonometry measured central pulse pressure, carotid-femoral pulse wave velocity (CFPWV), reflected wave augmentation index (AIx). In the HCM gene carriers, LV mass-to-volume ratio was extracted from clinically indicated echocardiograms as an index of hypertrophy. Associations were assessed using multivariable adjusted linear regression. The HCM group was comprised of 14 myosin binding protein C3 carriers, 13 myosin heavy chain 7 carriers, and 1 child with both. HCM and control groups did not differ by age, sex, height, body mass index, heart rate, or blood pressure. HCM carriers had significantly lower CFPWV than controls (4.46 ± 0.88 vs. 4.97 ± 0.44 m/s, p = 0.01) and higher AIx magnitude (27 ± 19 vs. 18 ± 7 %, p = 0.04). These associations persisted after adjustment for age, sex, height, heart rate, mean pressure, and medication use. Within the HCM group, LV hypertrophy was related to AIx but not CFPWV. CFPWV nor AIx differed by genotype. Aortic stiffness appears lower, but wave reflection appears higher in youth carrying HCM gene mutations. The degree of wave reflection appears correlated with LV hypertrophy in this high-risk cohort, suggesting that mitigation of wave reflection may possibly attenuate LV hypertrophy.

Entities:  

Keywords:  Aortic; Arterial stiffness; Children; Hypertrophic cardiomyopathy; Pediatric; Vascular

Mesh:

Year:  2016        PMID: 27041097      PMCID: PMC4899108          DOI: 10.1007/s00246-016-1373-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  26 in total

1.  Evaluation of left ventricular relaxation and filling pressures in obstructive hypertrophic cardiomyopathy: comparison between invasive hemodynamics and two-dimensional speckle tracking.

Authors:  Patrick Garceau; Shemy Carasso; Anna Woo; Chris Overgaard; Leonard Schwartz; Harry Rakowski
Journal:  Echocardiography       Date:  2012-05-17       Impact factor: 1.724

2.  Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension.

Authors:  Giuseppe Schillaci; Massimo R Mannarino; Giacomo Pucci; Matteo Pirro; Johny Helou; Gianluca Savarese; Gaetano Vaudo; Elmo Mannarino
Journal:  Hypertension       Date:  2007-01-02       Impact factor: 10.190

3.  Relation of left ventricular chamber stiffness at rest to exercise capacity in hypertrophic cardiomyopathy.

Authors:  Carlos Alberto Dumont; Lorenzo Monserrat; Jesús Peteiro; Rafaela Soler; Esther Rodriguez; Alberto Bouzas; Xusto Fernández; Ruth Pérez; Beatriz Bouzas; Alfonso Castro-Beiras
Journal:  Am J Cardiol       Date:  2007-04-04       Impact factor: 2.778

4.  Hypertrophic cardiomyopathy, fibrosis, and aortic stiffness: an unidentified association unraveled by magnetic resonance imaging.

Authors:  Harald P Kühl
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

5.  Early and late systolic wall stress differentially relate to myocardial contraction and relaxation in middle-aged adults: the Asklepios study.

Authors:  Julio A Chirinos; Patrick Segers; Ernst R Rietzschel; Marc L De Buyzere; Muhammad W Raja; Tom Claessens; Dirk De Bacquer; Martin St John Sutton; Thierry C Gillebert
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

6.  Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.

Authors:  S Betocchi; F Piscione; A Losi M; L Pace; M Boccalatte; P Perrone-Filardi; C Briguori; F Manganelli; Q Ciampi; M Salvatore; M Chiariello
Journal:  Am J Cardiol       Date:  1996-08-15       Impact factor: 2.778

7.  Arterial stiffness and cardiovascular events: the Framingham Heart Study.

Authors:  Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

Review 8.  Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies.

Authors:  K T Weber; C G Brilla; S E Campbell
Journal:  Cardiology       Date:  1992       Impact factor: 1.869

9.  Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.

Authors:  Jamie A Decker; Joseph W Rossano; E O'Brian Smith; Bryan Cannon; Sarah K Clunie; Corey Gates; John L Jefferies; Jeffrey J Kim; Jack F Price; William J Dreyer; Jeffrey A Towbin; Susan W Denfield
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

10.  Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.

Authors:  Thananya Boonyasirinant; Prabhakar Rajiah; Randolph M Setser; Michael L Lieber; Harry M Lever; Milind Y Desai; Scott D Flamm
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.